Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

Published:2010-10 Issue:10 Volume:9 Page:969-977
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Emre Murat,Tsolaki Magda,Bonuccelli Ubaldo,Destée Alain,Tolosa Eduardo,Kutzelnigg Alexandra,Ceballos-Baumann Andrés,Zdravkovic Slobodan,Bladström Anna,Jones Roy

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference26 articles.

1. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers;Lippa;Neurology,2007

2. Risk of dementia in Parkinson's disease: a community-based, prospective study;Aarsland;Neurology,2001

3. A systematic review of prevalence studies of dementia in Parkinson's disease;Aarsland;Mov Disord,2005

4. Clinical diagnostic criteria for dementia associated with Parkinson's disease;Emre;Mov Disord,2007

5. Visual perception in Parkinson disease dementia and dementia with Lewy bodies;Mosimann;Neurology,2004

Cited by 323 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10‐year follow‐up study;Alzheimer's & Dementia;2024-08-23

2. Factors Associated With Increased Health Care Utilization for Patients With Dementia With Lewy Bodies: A Narrative Review;Journal of Patient-Centered Research and Reviews;2024-07-16

3. Agmatine as a Promising Neuroprotective Strategy for Treating Neurological Disorders;International Journal of Pharmaceutical Investigation;2024-07-01

4. Relationship between donepezil and fracture risk in patients with dementia with Lewy bodies;Geriatrics & Gerontology International;2024-06-26

5. Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology;Journal of Clinical Medicine;2024-04-11